Mitsutaka Kohno
Overview
Explore the profile of Mitsutaka Kohno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshioka Y, Zhang Q, Wang X, Kitakaze T, Yamashita Y, Kohno M, et al.
Food Funct
. 2023 May;
14(11):5375-5390.
PMID: 37218309
Mung beans are among the important edible legumes cultivated in Asia, Southern Europe, and Northern America. Mung beans contain 20-30% proteins with high digestibility and possess biological activities, but detailed...
2.
Ohta S, Asanoma M, Irie N, Tachibana N, Kohno M
Metabolites
. 2022 Apr;
12(4).
PMID: 35448517
Complications associated with chronic kidney disease (CKD), which involves kidney inflammation, are a major health problem. Soy protein isolate (SPI) reportedly inhibits CKD exacerbation; however, its detailed action mechanism remains...
3.
Nakatani A, Li X, Miyamoto J, Igarashi M, Watanabe H, Sutou A, et al.
Biochem Biophys Res Commun
. 2018 May;
501(4):955-961.
PMID: 29777704
The 8-globulin-rich mung bean protein (MPI) suppresses hepatic lipogenesis in rodent models and reduces fasting plasma glucose and insulin levels in obese adults. However, its effects on mitigating high fat...
4.
Kohno M, Sugano H, Shigihara Y, Shiraishi Y, Motoyama T
J Nutr Sci
. 2018 Jan;
7:e2.
PMID: 29372050
The aim of the present study was to confirm the effects of a commercially available mung bean protein isolate (GLUCODIA™) on glucose and lipid metabolism. The main component of GLUCODIA™...
5.
Watanabe H, Inaba Y, Kimura K, Asahara S, Kido Y, Matsumoto M, et al.
J Nutr
. 2016 Dec;
147(1):52-60.
PMID: 27903831
Background: As the prevalence of nonalcoholic fatty liver disease (NAFLD), including steatosis and nonalcoholic steatohepatitis, is increasing, novel dietary approaches are required for the prevention and treatment of NAFLD. Objective:...
6.
Inoue N, Fujiwara Y, Kato M, Funayama A, Ogawa N, Tachibana N, et al.
Biosci Biotechnol Biochem
. 2015 Apr;
79(9):1528-34.
PMID: 25913002
The effects of dietary soybean β-conglycinin on lipid metabolism and energy consumption were studied in Wistar adult rats. Rats were fed, a diet containing casein (control group) or β-conglycinin (β-conglycinin...
7.
Wanezaki S, Tachibana N, Nagata M, Saito S, Nagao K, Yanagita T, et al.
Obes Res Clin Pract
. 2015 Apr;
9(2):168-74.
PMID: 25890430
Nonalcoholic fatty liver disease (NAFLD) has a variety of causes including calorie over-intake, an unbalanced diet, and/or genetic dysfunction of lipid metabolism. We hypothesized that NAFLD symptoms could be mitigated...
8.
Tachibana N, Yamashita Y, Nagata M, Wanezaki S, Ashida H, Horio F, et al.
Nutr Res
. 2014 Jan;
34(2):160-7.
PMID: 24461318
Although the underlying mechanism is unclear, β-conglycinin (βCG), the major component of soy proteins, regulates blood glucose levels. Here, we hypothesized that consumption of βCG would normalize blood glucose levels...
9.
Kojima M, Arishima T, Shimizu R, Kohno M, Kida H, Hirotsuka M, et al.
J Oleo Sci
. 2013 Dec;
62(12):997-1001.
PMID: 24292351
We examined the fecal fat excretion of mildly hypertriacylglycerolemic subjects who ingested soft cookies containing 1(3)-behenoyl-2,3(1)-dioleoyl-rac-glycerol (BOO) for 7 days. The subjects included 14 healthy men (average age; 44.9 ±...
10.
Inoue Y, Itoh H, Aoki M, Ogawa S, Yamane T, Baba T, et al.
Biosci Biotechnol Biochem
. 2012 Aug;
76(8):1549-51.
PMID: 22878184
Two weeks of feeding soy peptides containing 2% collagen peptides increased the levels of type I and III tropocollagen and their mRNAs. In contrast, the diet did not increase the...